BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15383203)

  • 41. Positron emission tomography for radiation treatment planning.
    Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
    Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.
    Schwartz DL; Ford EC; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellen B; Mattes D; Kinahan P; Meyer J; Phillips M; Leblanc M; Krohn K; Eary J; Laramore GE
    Head Neck; 2005 Jun; 27(6):478-87. PubMed ID: 15772953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Three-Dimensional Image Fusion of
    Yu Y; Zhang WB; Liu XJ; Guo CB; Yu GY; Peng X
    J Oral Maxillofac Surg; 2017 Jun; 75(6):1301.e1-1301.e15. PubMed ID: 28320612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PET/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination.
    Czernin J; Benz MR; Allen-Auerbach MS
    Eur J Radiol; 2010 Mar; 73(3):470-80. PubMed ID: 20097498
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET.
    Antoch G; Saoudi N; Kuehl H; Dahmen G; Mueller SP; Beyer T; Bockisch A; Debatin JF; Freudenberg LS
    J Clin Oncol; 2004 Nov; 22(21):4357-68. PubMed ID: 15514377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Cancer Radiother; 2005 Sep; 9(5):304-15. PubMed ID: 16087377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PET/CT in diagnostic oncology.
    Messa C; Bettinardi V; Picchio M; Pelosi E; Landoni C; Gianolli L; Gilardi MC; Fazio F
    Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):66-75. PubMed ID: 15243404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Technical aspects of positron emission tomography/computed tomography fusion planning.
    Brunetti J; Caggiano A; Rosenbluth B; Vialotti C
    Semin Nucl Med; 2008 Mar; 38(2):129-36. PubMed ID: 18243848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The benefit of functional-anatomical imaging with [18F]fluorodeoxyglucose utilizing a dual-head coincidence gamma camera with an integrated X-ray transmission system in non-small cell lung cancer.
    Eschmann SM; Bitzer M; Paulsen F; Friedel G; Besenfelder H; Horger M; Reimold M; Dittmann H; Pfannenberg AC; Bares R
    Nucl Med Commun; 2004 Sep; 25(9):909-15. PubMed ID: 15319596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beyond 18F-FDG: Characterization of PET/CT and PET/MR Scanners for a Comprehensive Set of Positron Emitters of Growing Application--18F, 11C, 89Zr, 124I, 68Ga, and 90Y.
    Soderlund AT; Chaal J; Tjio G; Totman JJ; Conti M; Townsend DW
    J Nucl Med; 2015 Aug; 56(8):1285-91. PubMed ID: 26135111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [PET-CT scan: a major progress toward fused, metabolic and functional images].
    Rusu V; Răileanu I
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):650-6. PubMed ID: 17571561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Positron Emission Tomography Computed Tomography: A Guide for the General Radiologist.
    Beadsmoore C; Newman D; MacIver D; Pawaroo D
    Can Assoc Radiol J; 2015 Nov; 66(4):332-47. PubMed ID: 26277234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.
    Vanuytsel LJ; Vansteenkiste JF; Stroobants SG; De Leyn PR; De Wever W; Verbeken EK; Gatti GG; Huyskens DP; Kutcher GJ
    Radiother Oncol; 2000 Jun; 55(3):317-24. PubMed ID: 10869746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A feasibility study of 18F-fluorodeoxyglucose positron emission tomography targeting and simultaneous integrated boost for intensity-modulated radiosurgery and radiotherapy.
    Solberg TD; Agazaryan N; Goss BW; Dahlbom M; Lee SP
    J Neurosurg; 2004 Nov; 101 Suppl 3():381-9. PubMed ID: 15537193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multi-Atlas-Based Attenuation Correction for Brain 18F-FDG PET Imaging Using a Time-of-Flight PET/MR Scanner: Comparison with Clinical Single-Atlas- and CT-Based Attenuation Correction.
    Sekine T; Burgos N; Warnock G; Huellner M; Buck A; Ter Voert EE; Cardoso MJ; Hutton BF; Ourselin S; Veit-Haibach P; Delso G
    J Nucl Med; 2016 Aug; 57(8):1258-64. PubMed ID: 27013697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mediastinal staging in Non-Small-Cell Lung Carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography.
    Harders SW; Madsen HH; Hjorthaug K; Arveschoug AK; Rasmussen TR; Meldgaard P; Hoejbjerg JA; Pilegaard HK; Hager H; Rehling M; Rasmussen F
    Cancer Imaging; 2014 Jun; 14(1):23. PubMed ID: 25608616
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical value of combined positron emission tomography/computed tomography imaging in the interpretation of 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography studies in cancer patients.
    Yeung HW; Schöder H; Smith A; Gonen M; Larson SM
    Mol Imaging Biol; 2005; 7(3):229-35. PubMed ID: 15912427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography imaging evaluation of esophageal cancer.
    Jadvar H; Henderson RW; Conti PS
    Mol Imaging Biol; 2006; 8(3):193-200. PubMed ID: 16565910
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A combined PET/CT scanner: the path to true image fusion.
    Townsend DW; Beyer T
    Br J Radiol; 2002 Nov; 75 Spec No():S24-30. PubMed ID: 12519732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.